AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
28 Feb 2011 04:00 PM
RNS
Director/PDMR Shareholding
28 Feb 2011 04:00 PM
RNS
Director/PDMR Shareholding
28 Feb 2011 04:00 PM
RNS
Director/PDMR Shareholding
28 Feb 2011 07:00 AM
RNS
Transaction in Own Shares
25 Feb 2011 07:00 AM
RNS
Transaction in Own Shares
24 Feb 2011 07:00 AM
RNS
Transaction in Own Shares
23 Feb 2011 07:00 AM
RNS
Transaction in Own Shares
22 Feb 2011 07:00 AM
RNS
Transaction in Own Shares
21 Feb 2011 04:00 PM
RNS
Director/PDMR Shareholding
21 Feb 2011 07:00 AM
RNS
Transaction in Own Shares
18 Feb 2011 02:30 PM
RNS
Share Repurchase Programme
18 Feb 2011 07:00 AM
RNS
Transaction in Own Shares
17 Feb 2011 07:00 AM
RNS
Transaction in Own Shares
16 Feb 2011 07:00 AM
RNS
Transaction in Own Shares
15 Feb 2011 07:00 AM
RNS
Transaction in Own Shares
14 Feb 2011 07:00 AM
RNS
Transaction in Own Shares
11 Feb 2011 07:00 AM
RNS
Transaction in Own Shares
10 Feb 2011 07:00 AM
RNS
Transaction in Own Shares
09 Feb 2011 07:00 AM
RNS
Transaction in Own Shares
07 Feb 2011 07:00 AM
RNS
Halts Phase III trial of Zibo
07 Feb 2011 07:00 AM
RNS
Transaction in Own Shares
04 Feb 2011 07:00 AM
RNS
US FDA gives new PDUFA date f
04 Feb 2011 07:00 AM
RNS
Transaction in Own Shares
03 Feb 2011 07:00 AM
RNS
Transaction in Own Shares
02 Feb 2011 07:00 AM
RNS
Transaction in Own Shares
01 Feb 2011 03:00 PM
RNS
Total Voting Rights
01 Feb 2011 07:00 AM
RNS
Transaction in Own Shares
31 Jan 2011 07:00 AM
RNS
Transaction in Own Shares
28 Jan 2011 07:00 AM
RNS
Transaction in Own Shares
27 Jan 2011 07:00 AM
RNS
Final Results part 3 of 3
27 Jan 2011 07:00 AM
RNS
Final Results part 2 of 3
27 Jan 2011 07:00 AM
RNS
Final Results part 1 of 3
27 Jan 2011 07:00 AM
RNS
Transaction in Own Shares
26 Jan 2011 09:00 AM
RNS
Notice of Results
26 Jan 2011 07:00 AM
RNS
Transaction in Own Shares
25 Jan 2011 07:00 AM
RNS
Transaction in Own Shares
24 Jan 2011 07:00 AM
RNS
Transaction in Own Shares
21 Jan 2011 07:00 AM
RNS
Response to US FDA CRL for Br
21 Jan 2011 07:00 AM
RNS
Transaction in Own Shares
20 Jan 2011 07:00 AM
RNS
Transaction in Own Shares
19 Jan 2011 07:00 AM
RNS
Transaction in Own Shares
18 Jan 2011 07:00 AM
RNS
Transaction in Own Shares
17 Jan 2011 07:00 AM
RNS
Transaction in Own Shares
14 Jan 2011 07:00 AM
RNS
Transaction in Own Shares
13 Jan 2011 07:00 AM
RNS
Transaction in Own Shares
12 Jan 2011 07:00 AM
RNS
Transaction in Own Shares
11 Jan 2011 07:00 AM
RNS
Transaction in Own Shares
10 Jan 2011 07:00 AM
RNS
Transaction in Own Shares
07 Jan 2011 07:00 AM
RNS
Transaction in Own Shares
06 Jan 2011 07:00 AM
RNS
Transaction in Own Shares
AstraZeneca PLC, known as AZN on the London Stock Exchange (LSE), is an Anglo-Swedish multinational pharmaceutical and biotechnology company. Founded on April 6, 1999, AstraZeneca was formed through the merger of the Swedish Astra AB and the British Zeneca Group. The company's roots trace back to 1913, when Astra AB was established by a group of doctors and apothecaries in Södertälje, Sweden. Throughout the twentieth century, AstraZeneca grew into one of the largest pharmaceutical companies in the world. It has made numerous corporate acquisitions, including Cambridge Antibody Technology (in 2006), MedImmune (in 2007), Spirogen (in 2013) and Definiens (by MedImmune in 2014). Today, AstraZeneca operates in over 100 countries and employs around 83,000 people. As a member of the LSEG, AZN continues to shape the global healthcare landscape. The company is committed to defeating diseases that impact people's health.
UK 100